Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
Holding CORT?
Track your performance easily

Corcept Therapeutics (CORT) Cash flow

762 Followers

Corcept Therapeutics Cash Flow

CORT's free cash flow for Q3 2024 was $72.19M. For the 2024 fiscal year, CORT's free cash flow was decreased by $6.99M and operating cash flow was $73.83M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 144.65M$ 127.04M$ 120.32M$ 167.89M$ 151.97M$ 136.12M
Investing Cash Flow
$ -96.15M$ 90.91M$ -114.33M$ 136.13M$ -119.26M$ -117.83M
Financing Cash Flow
$ -23.02M$ -148.72M$ -17.28M$ -302.59M$ 12.21M$ -28.64M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 551.18M$ 135.55M$ 66.33M$ 77.62M$ 76.19M$ 31.27M
Income Tax Paid Supplemental Data
$ 47.60M$ 47.60M$ 39.75M$ 9.10M$ 10.86M$ 6.74M
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 5.69M$ 5.81M$ 4.38M$ 16.23M$ 23.23M$ 8.42M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ 142.60M$ 126.90M$ 119.91M$ 167.42M$ 150.73M$ 135.03M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Corcept Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis